Details of the Drug Reposition

General Information of This Drug (ID: DMK3S9J)

Drug Name	GSK1144814 DMK3S9J

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)

2 Phase 1 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Schizophrenia	DISSRV2N	6A20	Phase 1	[1]
Alcohol dependence	DIS4ZSCO	6C40.2	Phase 1	[2]
------------------------------------------------------------------------------------

References

1	ClinicalTrials.gov (NCT01090440) Pharmacokinetics, Effect of Food, Safety and Tolerability of a New Tablet Formulation of GSK1144814 in Healthy Subjects (MNK112891) in GlaxoSmithKline.
2	ClinicalTrials.gov (NCT01181908) Alcohol Interaction Study. U.S. National Institutes of Health.